Literature DB >> 24327088

Infection through structured polymicrobial Gardnerella biofilms (StPM-GB).

Alexander Swidsinski1, Vera Loening-Baucke2, Werner Mendling3, Yvonne Dörffel4, Johannes Schilling2, Zaher Halwani5, Xue-feng Jiang6, Hans Verstraelen7, Sonja Swidsinski8.   

Abstract

BACKGROUND: We analysed data on bacterial vaginosis (BV) contradicting the paradigm of mono-infection.
METHODOLOGY: Tissues and epithelial cells of vagina, uterus, fallopian tubes and perianal region were investigated using fluorescence in situ hybridization (FISH) in women with BV and controls.
RESULTS: Healthy vagina was free of biofilms. Prolific structured polymicrobial (StPM) Gardnerella-dominated biofilm characterised BV. The intact StPM-Gardnerella-biofilm enveloped desquamated vaginal/prepuce epithelial cells and was secreted with urine and sperma. The disease involved both genders and occurred in pairs. Children born to women with BV were negative. Monotherapy with metronidazole, moxifloxacin or local antiseptics suppressed but often did not eradicate StPM-Gardnerella-biofilms. There was no BV without Gardnerella, but Gardnerella was not BV. Outside of StPM-biofilm, Gardnerella was also found in a subset of children and healthy adults, but was dispersed, temporal and did not transform into StPM-Gardnerella-biofilm.
CONCLUSIONS: StPM-Gardnerella-biofilm is an infectious subject. The assembly of single players to StPM-Gardnerella-biofilm is a not trivial every day process, but probably an evolutionary event with a long history of growth, propagation and selection for viability and ability to reshape the environment. The evolutionary memory is cemented in the structural differentiation of StPM-Gardnerella-biofilms and imparts them to resist previous and emerging challenges.

Entities:  

Mesh:

Year:  2013        PMID: 24327088     DOI: 10.14670/HH-29.10.567

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  32 in total

1.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

2.  Interaction of Gardnerella vaginalis and Vaginolysin with the Apical versus Basolateral Face of a Three-Dimensional Model of Vaginal Epithelium.

Authors:  Erin M Garcia; Vita Kraskauskiene; Jennifer E Koblinski; Kimberly K Jefferson
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

Review 3.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 4.  Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.

Authors:  Christina A Muzny; Jane R Schwebke
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 5.  Vaginal sialoglycan foraging by Gardnerella vaginalis: mucus barriers as a meal for unwelcome guests?

Authors:  Kavita Agarwal; Amanda L Lewis
Journal:  Glycobiology       Date:  2021-06-29       Impact factor: 4.313

6.  Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.

Authors:  Richard M Weeks; Alysha Moretti; Shuang Song; Kathryn E Uhrich; Andrey V Karlyshev; Michael L Chikindas
Journal:  Pathog Dis       Date:  2019-11-01       Impact factor: 3.951

7.  Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.

Authors:  Joana Castro; Patrícia Alves; Cármen Sousa; Tatiana Cereija; Ângela França; Kimberly K Jefferson; Nuno Cerca
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

8.  Gardnerella vaginalis Subgroups Defined by cpn60 Sequencing and Sialidase Activity in Isolates from Canada, Belgium and Kenya.

Authors:  John J Schellenberg; Teenus Paramel Jayaprakash; Niradha Withana Gamage; Mo H Patterson; Mario Vaneechoutte; Janet E Hill
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm.

Authors:  Liselotte Hardy; Vicky Jespers; Said Abdellati; Irith De Baetselier; Lambert Mwambarangwe; Viateur Musengamana; Janneke van de Wijgert; Mario Vaneechoutte; Tania Crucitti
Journal:  Sex Transm Infect       Date:  2016-03-10       Impact factor: 3.519

Review 10.  Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure.

Authors:  Catriona S Bradshaw; Rebecca M Brotman
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.